Levemir Flexpen

Levemir FlexPen: intermediate-acting insulin

Levemir FlexPen is an intermediate-acting insulin used to treat diabetes mellitus. The drug contains the active substance insulin detemir and is manufactured by Novo Nordisk A/S in Denmark.

Levemir FlexPen is presented in the form of a solution for subcutaneous injection with a concentration of 100 U/ml. The drug is synonymous with Levemir Penfill.

Indications for use

Levemir FlexPen is used to treat diabetes mellitus. The drug can be used in patients of any age, including children and the elderly.

Contraindications

The drug is not recommended for use in patients with increased individual sensitivity to insulin detemir or any of the components of the drug. It is also not recommended to use the drug in children under 6 years of age, since clinical studies have not been conducted in children under 6 years of age.

Side effects

Side effects observed in patients using Levemir FlexPen may be caused by the pharmacological effect of insulin. The most common side effect is hypoglycemia, which can develop when a dose of the drug is administered that is too high relative to the body's need for insulin.

Other side effects associated with effects on carbohydrate metabolism may include pale skin, cold sweats, fatigue, nervousness, tremors, anxiety, unusual tiredness or weakness, disorientation, difficulty concentrating, drowsiness, increased hunger, blurred vision. , headache, nausea, palpitations. Severe hypoglycemia can lead to loss of consciousness and/or convulsions, temporary or irreversible impairment of brain function, and even death.

Adverse reactions at injection sites may include local hypersensitivity reactions (redness, swelling and itching at the injection site), which are usually temporary, as well as lipodystrophy (as a result of failure to change the injection site within the same area).

Allergic reactions may include urticaria, skin rash, as well as generalized reactions - itching, increased sweating, gastrointestinal disorders, angioedema, difficulty in the throat and respiratory tract, anaphylactic shock.

Dosage and method of administration

The dosage of Levemir FlexPen should be determined individually for each patient depending on the level of glycemia and other factors. The drug is usually administered subcutaneously 1 or 2 times a day. The time of administration of the drug can be changed depending on the specific situation and the doctor’s recommendations.

Before using Levemir FlexPen, you must carefully read the instructions for use of the drug. For subcutaneous injections, the drug must be injected into the thigh, abdomen, or upper thigh. With each injection, it is necessary to use a new needle and change the injection site within the same area to avoid the development of lipodystrophy.

Conclusion

Levemir FlexPen is an intermediate-acting insulin used to treat diabetes mellitus. The drug can be used in patients of any age, including children and the elderly. Before using the drug, you must carefully read the instructions for use and consult your doctor. When using the drug, it is necessary to monitor the level of glycemia in the blood and monitor for possible side effects.